Javascript must be enabled to continue!
Effects of Apple Products on Plasma LDL Oxidation
View through CrossRef
Apple products contain polyphenol antioxidants, but human studies of apple antioxidant effects are few. The present study showed that apple and apple product intake decreased concentrations of plasma oxidized low‐density lipoprotein (LDL). Healthy, middle aged subjects were divided into 1 of 4 groups (N=16 each) for 1 mo treatment: apples (1 per day), multiple apple products (1 apple, 1 cup apple juice, 1 serving apple sauce per day), apple extract capsules (polyphenol content of 3 apples), or placebo capsules. Plasma oxidized LDL in plasma was determined by an ELISA assay kit (Alpco Diagnostics Inc.). Plasma oxidized LDL concentrations in each of the following groups showed decreased values for post‐intervention versus pre‐intervention: the apple group, the apple product group, and the apple extract group (paired t‐test p‐values < 0.05). Placebo did not show a significant effect. A possible mechanism might have been increases in the antioxidant enzyme superoxide dismutase 1 since apple intake is reported to affect these activities. However, in the present study, no consistent effect was seen for any of the apple groups for changes in superoxide dismutase 1 in red blood cells. In summary, apple product consumption can decrease plasma contents of oxidized LDL, which could present a reasonable strategy for nutritional prevention of atherosclerosis
Title: Effects of Apple Products on Plasma LDL Oxidation
Description:
Apple products contain polyphenol antioxidants, but human studies of apple antioxidant effects are few.
The present study showed that apple and apple product intake decreased concentrations of plasma oxidized low‐density lipoprotein (LDL).
Healthy, middle aged subjects were divided into 1 of 4 groups (N=16 each) for 1 mo treatment: apples (1 per day), multiple apple products (1 apple, 1 cup apple juice, 1 serving apple sauce per day), apple extract capsules (polyphenol content of 3 apples), or placebo capsules.
Plasma oxidized LDL in plasma was determined by an ELISA assay kit (Alpco Diagnostics Inc.
).
Plasma oxidized LDL concentrations in each of the following groups showed decreased values for post‐intervention versus pre‐intervention: the apple group, the apple product group, and the apple extract group (paired t‐test p‐values < 0.
05).
Placebo did not show a significant effect.
A possible mechanism might have been increases in the antioxidant enzyme superoxide dismutase 1 since apple intake is reported to affect these activities.
However, in the present study, no consistent effect was seen for any of the apple groups for changes in superoxide dismutase 1 in red blood cells.
In summary, apple product consumption can decrease plasma contents of oxidized LDL, which could present a reasonable strategy for nutritional prevention of atherosclerosis.
Related Results
A-231 A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C
A-231 A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C
Abstract
Background
Patients at high risk for Atherosclerotic Cardiovascular Disease (ASCVD), who do not achieve adequate loweri...
Developing a Modified Low-Density Lipoprotein (M-LDL-C) Friedewald’s Equation as a Substitute for Direct LDL-C Measure in a Ghanaian Population: A Comparative Study
Developing a Modified Low-Density Lipoprotein (M-LDL-C) Friedewald’s Equation as a Substitute for Direct LDL-C Measure in a Ghanaian Population: A Comparative Study
Despite the availability of several homogenous LDL-C assays, calculated Friedewald’s LDL-C equation remains the widely used formula in clinical practice. Several novel formulas dev...
An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
Abstract
Background
The accurate measurement of Low-density lipoprotein cholesterol (LDL-C) is critical in the decision to utilize the new lipid-low...
e0303 Significance of oxidised low-density lipoprotein in coronary atherosclerotic heart disease
e0303 Significance of oxidised low-density lipoprotein in coronary atherosclerotic heart disease
Objective
In this study, control group are people with normal coronary arteries. This study is to discuss the relationship between LDL, OX-LDL and control group, ...
Cumulative LDL-C Burden and Incident Acute Coronary Syndrome in Type 2 Diabetes
Cumulative LDL-C Burden and Incident Acute Coronary Syndrome in Type 2 Diabetes
Background: Low-density lipoprotein cholesterol (LDL-C) is a central modifiable driver of atherosclerotic cardiovascular disease, yet cardiovascular risk in type 2 diabetes mellitu...
The effect of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year long-term prognosis in patients with premature coronary heart disease---a multicenter, observational results
The effect of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year long-term prognosis in patients with premature coronary heart disease---a multicenter, observational results
Abstract
Background
Low density lipoprotein cholesterol (LDL-C) level is a strong predictor of premature coronary heart disease(...
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
Abstract
Background
Heterozygous familial hypercholesterolemia (HeFH) is characterized by lifelong elevated LDL-C and inc...
Overview on LDL‐apheresis in cardiovascular diseases
Overview on LDL‐apheresis in cardiovascular diseases
LDL apheresis has been widely accepted as an effective treatment for hypercholesterolemic patients who are resistant to drug and conventional therapy such as in case of familial hy...

